Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Lu MY"" wg kryterium: Autor


Wyświetlanie 1-9 z 9
Tytuł :
Correction: Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
Autorzy :
Lin CY; Department of Oral and Maxillofacial Surgery, Chi Mei Hospital, Tainan, Taiwan.
Hsieh PL; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Liao YW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Peng CY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Lu MY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Yang CH; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Yu CC; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Liu CM; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2018 May 15; Vol. 9 (37), pp. 24870. Date of Electronic Publication: 2018 May 15 (Print Publication: 2018).
Typ publikacji :
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł :
Targeting LncRNA HOTAIR suppresses cancer stemness and metastasis in oral carcinomas stem cells through modulation of EMT.
Autorzy :
Lu MY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Liao YW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Chen PY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Hsieh PL; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Fang CY; Department of Dentistry, Taipei Municipal Wanfang Hospital, Taipei, Taiwan.; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.
Wu CY; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Yen ML; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Peng BY; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Wang DP; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Cheng HC; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Wu CZ; School of Dentistry, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Shih YH; Department of Dentistry, Taipei Municipal Wanfang Hospital, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Wang DJ; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Yu CC; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Tsai LL; Department of Dentistry, Taipei Municipal Wanfang Hospital, Taipei, Taiwan.; Department of Dentistry, Taipei Medical University Hospital, Taipei, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Oct 07; Vol. 8 (58), pp. 98542-98552. Date of Electronic Publication: 2017 Oct 07 (Print Publication: 2017).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.
Autorzy :
Hu FW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yu CC; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Hsieh PL; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Liao YW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Lu MY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Chu PM; Department of Anatomy and Graduate Institute of Biomedical Sciences, School of Medicine, China Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Sep 28; Vol. 8 (55), pp. 93912-93923. Date of Electronic Publication: 2017 Sep 28 (Print Publication: 2017).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
Autorzy :
Lin CY; Department of Oral and Maxillofacial Surgery, Chi Mei Hospital, Tainan, Taiwan.
Hsieh PL; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Liao YW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Peng CY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Lu MY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Yang CH; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Yu CC; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Liu CM; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Sep 08; Vol. 8 (46), pp. 80900-80908. Date of Electronic Publication: 2017 Sep 08 (Print Publication: 2017).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Andrographolide impedes cancer stemness and enhances radio-sensitivity in oral carcinomas via miR-218 activation.
Autorzy :
Yang PY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Oral Medicine Center, Chung Shan Medical University, Taichung, Taiwan.
Hsieh PL; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.
Wang TH; Tissue Bank, Chang Gung Memorial Hospital, Tao-Yuan, Taiwan.; Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Tao-Yuan, Taiwan.; Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Tao-Yuan, Taiwan.
Yu CC; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.; Oral Medicine Center, Chung Shan Medical University, Taichung, Taiwan.
Lu MY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.; Oral Medicine Center, Chung Shan Medical University, Taichung, Taiwan.
Liao YW; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.
Lee TH; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.
Peng CY; School of Dentistry, Chung Shan Medical University, Taichung, Taiwan.; Department of Dentistry, Chung Shan Medical University Hospital, Taichung, Taiwan.; Institute of Oral Sciences, Chung Shan Medical University, Taichung, Taiwan.; Oral Medicine Center, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4196-4207.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Agents, Phytogenic/*administration & dosage
Carcinoma, Squamous Cell/*therapy
Diterpenes/*administration & dosage
MicroRNAs/*genetics
Mouth Neoplasms/*therapy
Radiation-Sensitizing Agents/*administration & dosage
Animals ; Antineoplastic Agents, Phytogenic/pharmacology ; Carcinoma, Squamous Cell/genetics ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Proliferation/radiation effects ; Cell Survival/drug effects ; Cell Survival/radiation effects ; Diterpenes/pharmacology ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Mice ; Mouth Neoplasms/genetics ; Neoplastic Stem Cells/drug effects ; Neoplastic Stem Cells/radiation effects ; Polycomb Repressive Complex 1/genetics ; Radiation-Sensitizing Agents/pharmacology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.
Autorzy :
Chang HH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Liu YL; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Pediatrics, Taipei Medical University Hospital, Taipei, Taiwan.
Lu MY; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Jou ST; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Yang YL; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lin DT; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lin KH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Tzen KY; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Yen RF; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lu CC; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Liu CJ; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Peng SS; Department of Medical Imaging, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Jeng YM; Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Huang SF; Division of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli County, Taiwan.
Lee H; Department of Life Science, National Taiwan University, Taipei, Taiwan.; Institutes of Zoology, National Taiwan University, Taipei, Taiwan.
Juan HF; Department of Life Science, National Taiwan University, Taipei, Taiwan.; Institutes of Molecular and Cellular Biology, National Taiwan University, Taipei, Taiwan.
Huang MC; Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
Liao YF; Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Lee YL; Department of Nursing, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Nursing, Central Taiwan University of Science and Technology, Taichung, Taiwan.
Hsu WM; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4360-4372.
Typ publikacji :
Journal Article
MeSH Terms :
Neuroblastoma/*mortality
Nursing, Team/*methods
Adolescent ; Child ; Child, Preschool ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Neoplasm Staging ; Neuroblastoma/pathology ; Survival Rate ; Taiwan
Czasopismo naukowe
Tytuł :
Dynamics of PBMC gene expression in hepatitis C virus genotype 1-infected patients during combined peginterferon/ribavirin therapy.
Autorzy :
Lu MY; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsieh TJ; Department of Genome Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsi E; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai PC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Tsai YS; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin CC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hsieh MH; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Hou NJ; Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Occupational Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.; Faculty of Internal Medicine, College of Medicine, and Graduate Institute of Clinical Medicine, and Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.; Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2016 Sep 20; Vol. 7 (38), pp. 61325-61335.
Typ publikacji :
Journal Article
MeSH Terms :
Hepatitis C, Chronic/*blood
Interferon-alpha/*therapeutic use
Leukocytes, Mononuclear/*metabolism
Polyethylene Glycols/*therapeutic use
Ribavirin/*therapeutic use
Adult ; Aged ; Antiviral Agents/therapeutic use ; Cohort Studies ; Drug Therapy, Combination ; Female ; Gene Expression Profiling ; Gene Expression Regulation ; Gene Expression Regulation, Neoplastic ; Genotype ; Hepacivirus/genetics ; Hepatitis C, Chronic/drug therapy ; Humans ; Male ; Middle Aged ; Sequence Analysis, RNA ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.
Autorzy :
Liu YL; Department of Pediatrics, Taipei Medical University Hospital, Taipei, Taiwan.; PhD Program in Translational Medicine, National Taiwan University and Academia Sinica, Taipei, Taiwan.; Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Lu MY; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Chang HH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lu CC; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lin DT; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Jou ST; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Yang YL; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lee YL; Department of Nursing, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Huang SF; Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
Jeng YM; Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lee H; Department of Life Science, College of Life Science, National Taiwan University, Taipei, Taiwan.
Miser JS; Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan.; College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Lin KH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Liao YF; Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.
Hsu WM; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan.
Tzen KY; Department of Nuclear Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.; Molecular Imaging Center, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2016 Apr 05; Vol. 7 (14), pp. 18774-86.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Dihydroxyphenylalanine/*analogs & derivatives
Fluorodeoxyglucose F18/*analysis
Neuroblastoma/*diagnostic imaging
Neuroblastoma/*therapy
Positron-Emission Tomography/*methods
Radiopharmaceuticals/*analysis
Cohort Studies ; Dihydroxyphenylalanine/analysis ; Dihydroxyphenylalanine/pharmacokinetics ; Disease-Free Survival ; Female ; Fluorodeoxyglucose F18/pharmacokinetics ; Genomics ; Humans ; Infant ; Male ; Neuroblastoma/genetics ; Neuroblastoma/metabolism ; Prognosis ; Radiopharmaceuticals/pharmacokinetics ; Treatment Outcome
Czasopismo naukowe
Tytuł :
GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.
Autorzy :
Ho WL; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan. Department of Pediatrics, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan. School of Medicine, Fu Jen Catholic University, New Taipei City, Taiwan.
Chou CH; Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan.
Jeng YM; Department of Pathology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lu MY; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Yang YL; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Jou ST; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lin DT; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Chang HH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Lin KH; Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Hsu WM; Department of Surgery, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan.
Huang MC; Graduate Institute of Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan. Research Center for Developmental Biology and Regenerative Medicine, National Taiwan University, Taipei, Taiwan.
Pokaż więcej
Źródło :
Oncotarget [Oncotarget] 2014 Dec 15; Vol. 5 (23), pp. 12247-59.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
N-Acetylgalactosaminyltransferases/*metabolism
Neuroblastoma/*pathology
Receptor, IGF Type 1/*metabolism
Animals ; Child ; Child, Preschool ; Female ; Fluorescent Antibody Technique ; Gene Knockdown Techniques ; Heterografts ; Humans ; Immunohistochemistry ; Infant ; Infant, Newborn ; Kaplan-Meier Estimate ; Male ; Mice ; Mice, Nude ; Neuroblastoma/mortality ; Phenotype ; Prognosis ; Signal Transduction/physiology ; Transfection
Czasopismo naukowe
    Wyświetlanie 1-9 z 9

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies